MAPT and Alzheimer disease: No associations were found between sleep disturbances (wake time after sleep onset, total sleep time, and Epworth Sleepiness Scale) and CSF biomarkers (Aβ42, tau, P-tau, and hypocretin-1) in either the whole assessed population or in the AD+MCI-AD group only (n = 29).